Millions of women were exposed to DES before it was pulled from the market in the early 1970s. In recent years, evidence indicating these women are at an increased risk of breast cancer has been growing.
New York, New York (PRWEB) January 10, 2013
DES breast cancer lawsuits are being investigated by Bernstein Liebhard LLP on behalf of women who developed breast cancer that may be linked to their mothers’ use of diethylstilbestrol (DES) during pregnancy. According to a report from the Associated Press, Eli Lilly settled the first DES breast cancer lawsuit to go to trial on January 9th, just two days into testimony. The lawsuit, filed in U.S. District Court, District of Massachusetts by four sisters who are DES daughters, is among more than 50 claims pending throughout the U.S. by women who allege DES caused them to develop breast cancer.* (Fecho, et al. v. Eli Lilly & Co., et al., No. 11-10152)
“Millions of women were exposed to DES before it was pulled from the market in the early 1970s. In recent years, evidence indicating these women are at an increased risk of breast cancer has been growing,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to DES daughters who have been diagnosed with breast cancer.
DES Daughters and Breast Cancer
According to the U.S. Centers for Disease Control (CDC), DES daughters were born from 1938 through 1971. DES was given to millions of pregnant women during this period to prevent miscarriage and premature birth. The drug was pulled off the market after the daughters of these women were found to be at risk for a rare form of vaginal cancer called clear cell adenocarcinoma. According to the CDC, DES daughters may be at risk for other health problems, including infertility, reproductive tract issues, pregnancy complications and breast cancer. **
According to the CDC, a study published in 2002 found that DES daughters over age 40 are 2.5 more times likely to develop breast cancer compared to women over 40 who were not exposed to DES.*** A second study published in 2006 found that the daughters of women who took DES face a 90% increased risk of cancer after age 40, and a 200% increased risk after age 50.****
According to the Associated Press, legal experts believe the Eli Lilly DES breast cancer lawsuit settlement could spark a wave of settlements in similar claims. DES daughters who developed breast cancer may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. The attorneys of Bernstein Liebhard LLP are offering free legal evaluations to DES daughters with breast cancer. A wealth of information about DES breast cancer lawsuits is also available at the Firm’s website, at http://www.consumerinjurylawyers.com/, or by calling 1-877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP